
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT The most common mutation in cystic fibrosis, ΔF508, results in a cystic fibrosis transmembrane conductance regulator (CFTR) protein that is retained in the endoplasmic reticulum
(ER). Retention is dependent upon chaperone proteins, many of which require Ca++ for optimal activity. Interfering with chaperone activity by depleting ER Ca++ stores might allow functional
ΔF508-CFTR to reach the cell surface. We exposed several cystic fibrosis cell lines to the ER Ca++ pump inhibitor thapsigargin and evaluated surface expression of ΔF508-CFTR. Treatment
released ER-retained ΔF508-CFTR to the plasma membrane, where it functioned effectively as a Cl− channel. Treatment with aerosolized calcium-pump inhibitors reversed the nasal epithelial
potential defect observed in a mouse model of ΔF508-CFTR expression. Thus, ER calcium-pump inhibitors represent a potential target for correcting the cystic fibrosis defect. Access through
your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12
print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be
subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR
CONTENT BEING VIEWED BY OTHERS SARS-COV-2 VIRAL ENTRY AND REPLICATION IS IMPAIRED IN CYSTIC FIBROSIS AIRWAYS DUE TO ACE2 DOWNREGULATION Article Open access 10 January 2023 SFPQ RESCUES
F508DEL-CFTR EXPRESSION AND FUNCTION IN CYSTIC FIBROSIS BRONCHIAL EPITHELIAL CELLS Article Open access 17 August 2021 MACROCYCLE-STABILIZATION OF ITS INTERACTION WITH 14-3-3 INCREASES PLASMA
MEMBRANE LOCALIZATION AND ACTIVITY OF CFTR Article Open access 23 June 2022 REFERENCES * Davis, P.B., Drumm, M. & Konstan, M.W. Cystic fibrosis. _Am. J. Respir. Crit. Care Med._ 154,
1229–1256 (1996). Article CAS Google Scholar * Sheppard, D.N. & Welsh, M.J. Structure and function of the CFTR chloride channel. _Physiol. Rev._ 79, Suppl. S23–S45 (1999). Article
CAS Google Scholar * Thomas, P.J., Shenbagamurthi, P., Sondek, J., Hullihen, J.M. & Pedersen, P.L. The cystic fibrosis transmembrane conductance regulator: Effects of the most common
cystic fibrosis-causing mutation on the secondary structure and the stability of a synthetic peptide. _J. Biol. Chem._ 267, 5727–5730 (1992). CAS PubMed Google Scholar * Cheng, S.H. et
al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. _Cell_ 63, 827–834 (1990). Article CAS Google Scholar * Ward, C.L., Omura, S.
& Kopito, R.R. Degradation of CFTR by the ubiquitin-proteasome pathway. _Cell_ 83, 122–127 (1995). Article Google Scholar * Egan, M.E., Schwiebert, E.M. & Guggino, W.B.
Differential expression of outwardly rectifying chloride channels and CFTR induced by low temperature in CF airway epithelial cells. _Am. J. Physiol._ 268, C243–C251 (1995). Article CAS
Google Scholar * Rubenstein, R.C., Egan, M.E. & Zeitlin, P.L. _In vitro_ pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis
epithelial cells containing ΔF508-CFTR. _J. Clin. Invest._ 100, 2457–2465 (1997). Article CAS Google Scholar * Hwang, T.C., Wang, F., Yang, I.C. & Reenstra, W.W. Genistein potentiates
wild-type and ΔF508-CFTR channel activity. _Am. J. Physiol._ 273, C988–C998 (1997). Article CAS Google Scholar * Dalemans, W. et al. Altered chloride ion channel kinetics associated with
the ΔF508 cystic fibrosis mutation. _Nature_ 354, 526–528 (1991). Article CAS Google Scholar * Maitra, R., Shaw, C.M., Stanton, B.A. & Hamilton, J.W. Increased functional cell
surface expression of CFTR and ΔF508-CFTR by the anthracycline doxorubicin. _Am. J. Physiol._ 280, C1031C1037 (2001). * Nigam, S.K. et al. A set of endoplasmic reticulum proteins possessing
properties of molecular chaperones includes Ca(2+)-binding proteins and members of the thioredoxin superfamily. _J. Biol. Chem._ 269, 1744–1749 (1994). CAS PubMed Google Scholar *
Ellgaard, L., Molinari, M. & Helenius, A. Setting the standards: Quality control in the secretory pathway. _Science_ 286, 1882–1888 (1999). Article CAS Google Scholar * Montero, M. et
al. Ca homeostasis in the endoplasmic reticulum: Coexistence of high and low [Ca] subcompartments in intact HeLa cells. _J. Cell Biol._ 139, 601–611 (1997). Article CAS Google Scholar *
Zeitlin, P.L. et al. A cystic fibrosis bronchial epithelial cell line: Immortalization by adeno-12-SV40 infection. _Am. J. Resp. Cell. Mol. Biol._ 4, 313–319 (1991). Article CAS Google
Scholar * Kunzelman, K. et al. An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the DF508-CFTR mutation. _Am. J. Resp. Cell. Mol. Biol._ 8, 522–529 (1993).
Article Google Scholar * Haws, C.M. et al. ΔF508-CFTR channels: Kinetics, activation by forskolin, and potentiation by xanthines. _Am. J. Physiol._ 270, C1544–C1555 (1996). Article CAS
Google Scholar * Schultz, B.D. et al. Glibenclamide blockade of CFTR chloride channels. _Am. J. Physiol._ 271, L192–L200 (1996). CAS PubMed Google Scholar * Verkman, A.S. Development and
biological applications of chloride-sensitive fluorescent indicators. _Am. J. Physiol._ 259, C375–C388 (1990). Article CAS Google Scholar * Zhang, Z.R., Zeltwanger, S. & McCarty,
N.A. Direct comparison of NPPB and DPC as probes of CFTR expressed in Xenopus oocytes. _J. Membr. Biol._ 175, 35–52 (2000). Article CAS Google Scholar * Schoumacher, R.A. et al. A cystic
fibrosis pancreatic adenocarcinoma cell line. _Proc. Natl. Acad. Sci. USA_ 87, 4012–4016 (1990). Article CAS Google Scholar * Grubb, B., Lazarowski, E., Knowles, M. & Boucher, R.C.
Isobutylmethylxanthine fails to stimulate chloride secretion in cystic fibrosis airway epithelia. _Am. J. Resp. Cell. Mol. Biol._ 8, 454–460 (1993). Article CAS Google Scholar *
Choudhury, P., Liu, Y., Bick, R.J. & Sifers, R.N. Intracellular association between UDP-glucose:glycoprotein glucosyltransferase and an incompletely folded variant of α1-antitrypsin. _J.
Biol. Chem._ 272, 13446–13451 (1997). Article CAS Google Scholar * Shachar, I., Rabinovich, E., Kerem, A. & Bar-Nun, S. Thiol-reducing agents and calcium perturbants alter
intracellular sorting of immunoglobulin M. _J. Biol. Chem._ 269, 27344–27350 (1994). CAS PubMed Google Scholar * Tsien, R.Y. New calcium indicators and buffers with high selectivity
against magnesium and protons: Design, synthesis and properties of prototype structures. _Biochem. J._ 19, 2396–2404 (1980). Article CAS Google Scholar * Mason, M.J., Garcia-Rodriguez, C.
& Grinstein, S. Coupling between intracellular Ca2+ stores and the Ca2+ permeability of the plasma membrane. Comparison of the effects of thapsigargin, 2, 5-di-(tert-butyl)-1,
4-hydroquinone, and cyclopiazonic acid in rat thymic lymphocytes. _J. Biol. Chem._ 266, 20856–20862 (1991). CAS PubMed Google Scholar * Booth, C. & Koch, G.L.E. Perturbation of
cellular calcium induces secretion of luminal ER proteins. _Cell_ 59, 729–737 (1989). Article CAS Google Scholar * Lee, A.S. The glucose-regulated proteins: Stress induction and clinical
applications. _TIBS_ 26, 504–10 (2001). CAS PubMed Google Scholar * Llewellyn, D.H., Kendall, J.M., Sheikh, F.N. & Campbell, A.K. Induction of calreticulin expression in HeLa cells by
depletion of the endoplasmic reticulum Ca++ store and inhibition of N-linked glycosylation. _Biochem. J._ 318, 555–560 (1996). Article CAS Google Scholar * Zeiher, B.G. et al. A mouse
model for the ΔF508 allele of cystic fibrosis. _J. Clin. Invest._ 96, 2051–2064 (1995). Article CAS Google Scholar * Grubb, B.R., Vick, R.N. & Boucher, R.C. Hyperabsorption of Na+ and
raised Ca(2+)-mediated Cl− secretion in nasal epithelia of CF mice. _Am. J. Physiol._ 266, C1478–C1483 (1994). Article CAS Google Scholar * Zeitlin, P.L. Novel pharmacologic therapies
for cystic fibrosis. _J. Clin. Invest._ 103, 447–452 (1999). Article CAS Google Scholar * Rosenfeld, M.A. & Collins, F.S. Gene therapy for cystic fibrosis. _Chest._ 109, 241–52
(1996). Article CAS Google Scholar * Sato, S., Ward, C.L., Krouse, M.E., Wine, J.J. & Kopito, R.R. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis
mutation. _J. Biol. Chem._ 271, 635–638 (1996). Article CAS Google Scholar * Brown, C.R., Hong-Brown, L.Q. & Welch, W.J. Correcting temperature-sensitive protein folding defects. _J.
Clin. Invest._ 99, 1432–1444 (1997). Article CAS Google Scholar * Pind, S., Riordan, J.R. & Williams, D.B. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in
the biogenesis of the cystic fibrosis transmembrane conductance regulator. _J. Biol. Chem._ 269, 12784–12788 (1994). CAS PubMed Google Scholar * Meacham, G.C. et al. The Hdj-2/HSC70
chaperone pair facilitates early steps in CFTR biogenesis. _EMBO J._ 18, 1492–1505 (1999). Article CAS Google Scholar * Lodish, H.F. & Kong, N. Perturbation of cellular calcium blocks
exit of secretory proteins from the rough endoplasmic reticulum. _J. Biol. Chem._ 265, 10893–10899 (1990). CAS PubMed Google Scholar * Wong, W.L., Brostrom, M.A., Kuznetsov, G.,
Gmitter-Yellen, D. & Brostrom, C.O. Inhibition of protein synthesis and early protein processing by thapsigargin in cultured cells. _Biochem. J._ 289, 71–79 (1993). Article CAS Google
Scholar * Hofer, A.M. & Machen, T.E. Technique for _in situ_ measurement of calcium in intracellular inositol 1,4,5-triphosphate-sensitive stores using the fluorescent indicator
mag-fura-2. _Proc. Nat. Acad. Sci. USA_ 90, 2598–2602 (1993). Article CAS Google Scholar * Christensen, S.B., Andersen, A., Poulsen, J.C.J. & Treiman, M. Derivatives of thapsigargin
as probes of its binding site on endoplasmic reticulum Ca-ATPase: Stereoselectivity and important functional groups. _FEBS Lett._ 335, 345–348 (1993). Article CAS Google Scholar * Tsien,
R.Y., Pozzan, T. & Rink, T.J. Calcium homeostasis in intact lymphocytes: Cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. _J. Cell Biol._ 94,
325–334 (1982). Article CAS Google Scholar * Chao, A., Kouyama, K., Heist, E., Dong, Y. & Gardner, P. Calcium- and CaMKII-dependent chloride secretion induced by the microsomal
Ca-ATPase inhibitor 2,5-di-(_tert_-butyl)-1,4-hydroquinone in cystic fibrosis pancreatic epithelial cells. _J. Clin. Invest._ 96, 1794–1801 (1995). Article CAS Google Scholar * Crawford,
I. et al. Immunocytochemical localization of THE cystic fibrosis gene product CFTR. _Proc. Nat. Acad. Sci. USA_ 88, 9262–9266 (1991). Article CAS Google Scholar * Gottardi, C.J. &
Caplan, M.J. An ion transporting ATPase encodes multiple apical localization signals. _J. Cell Biol._ 121, 283–293 (1993). Article CAS Google Scholar * Biemesderfer, D., Dekan, G.,
Aronson, P.S. & Farquhar, M.G. Assembly of distinctive coated pit and microvillar microdomains in the renal brush border. _Am. J. Physiol._ 262, F55–F67 (1992). CAS PubMed Google
Scholar Download references ACKNOWLEDGEMENTS We thank M. Drumm for ΔF508-CFTR mice; W. Guggino, M. Blaustein, P. Aronson, J. Burger, G. Fyfe, G. Giebisch, G. Haddad, P. De Camilli, K.
Bottomly, R. Lifton and members of the Caplan lab group for suggestions and readings of the manuscript; S.A. Mentone for help with electron microscopy; V. Rajendran and M.W. Nason for
technical support; and M. Kashgarian for assistance in evaluating histopathologic specimens. This work was supported by the Alyward Family/Pitney Bowes Gift Fund, Panacea Pharmaceuticals
(M.E.E. and M.J.C.) and by NIH grants DK53428 (to M.E.E.), DK50230 (to J.G.), HD32573 (to J.G.), GM42136 (to M.J.C.) and DK17433 (to J.G. and M.J.C.). AUTHOR INFORMATION Author notes *
Judith Glöckner-Pagel and Catherine A. Ambrose: J.G.-P. and C.A.A. contributed equally to this study. AUTHORS AND AFFILIATIONS * Department of Pediatrics, Yale University School of Medicine,
New Haven, Connecticut, USA Marie E. Egan, Catherine A. Ambrose, Paula A. Cahill, Lamiko Pappoe & Naomi Balamuth * Department of Surgery, Yale University School of Medicine, New Haven,
Connecticut, USA John Geibel * Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut, USA Marie E. Egan, Judith Glöckner-Pagel, Edward
Cho, Susan Canny, Carsten A. Wagner, John Geibel & Michael J. Caplan Authors * Marie E. Egan View author publications You can also search for this author inPubMed Google Scholar * Judith
Glöckner-Pagel View author publications You can also search for this author inPubMed Google Scholar * Catherine A. Ambrose View author publications You can also search for this author
inPubMed Google Scholar * Paula A. Cahill View author publications You can also search for this author inPubMed Google Scholar * Lamiko Pappoe View author publications You can also search
for this author inPubMed Google Scholar * Naomi Balamuth View author publications You can also search for this author inPubMed Google Scholar * Edward Cho View author publications You can
also search for this author inPubMed Google Scholar * Susan Canny View author publications You can also search for this author inPubMed Google Scholar * Carsten A. Wagner View author
publications You can also search for this author inPubMed Google Scholar * John Geibel View author publications You can also search for this author inPubMed Google Scholar * Michael J.
Caplan View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Michael J. Caplan. ETHICS DECLARATIONS COMPETING INTERESTS
These studies were supported to a small extent by a sponsored research agreement between Yale University and Panacea Pharmaceuticals, a small biotech firm that has licensed this technology
from Yale University. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Egan, M., Glöckner-Pagel, J., Ambrose, C. _et al._ Calcium-pump inhibitors induce
functional surface expression of ΔF508-CFTR protein in cystic fibrosis epithelial cells. _Nat Med_ 8, 485–492 (2002). https://doi.org/10.1038/nm0502-485 Download citation * Received: 13
March 2002 * Accepted: 29 March 2002 * Issue Date: 01 May 2002 * DOI: https://doi.org/10.1038/nm0502-485 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this
content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative